Table 2. Number of Insulin Treatment Visits in the US by Type of Insulina.
| Year | Visits, No. (%) | Total insulin visits, No. (95% CI) | ||
|---|---|---|---|---|
| Biosimilar insulin | Human insulin | Analog insulin | ||
| 2016 | 0 | 441 461 (7.3) | 5 604 310 (92.7) | 6 045 771 (5 077 843-7 013 699) |
| 2017 | 134 502 (2.6) | 317 319 (6.0) | 4 806 406 (91.4) | 5 258 227 (4 361 173-6 155 281) |
| 2018 | 335 839 (5.9) | 417 353 (7.3) | 4 935 979 (86.8) | 5 689 171 (4 778 335-6 600 007) |
| 2019 | 450 498 (7.6) | 488 683 (8.2) | 4 987 401 (84.2) | 5 926 582 (4 977 736-6 875 428) |
| 2020 | 405 893 (8.2) | 271 069 (5.5) | 4 263 978 (86.3) | 4 940 940 (4 098 016-5 783 864) |
a
Data were collected from the IQVIA National Disease and Therapeutic Index, 2016-2020.